If you are shopping for an oral NAD+ supplement, NMN and NR are the evidence-based places to start. Both are NAD+ precursors, and both have repeatedly raised circulating NAD+ in human studies. A 2026 head-to-head trial found that 14 days of NMN and NR produced comparable increases in whole-blood NAD+ in healthy adults.[1]
NMN now has several randomized human trials showing more than biochemical activity. Studies have reported improvements in six-minute walking performance in healthy middle-aged adults, muscle insulin sensitivity in postmenopausal women with prediabetes, and some muscle-function measures in older men.[3][5][6]
Direct oral NAD+ is a newer branch of the category. One proprietary formulation raised intracellular whole-blood NAD+ in a short 2026 randomized trial, but that evidence is much narrower than the repeated human literature for NMN and NR.[9]
The NAD+ supplement aisle in one minute
NAD+ is a coenzyme your cells use constantly. It helps move electrons through energy-producing reactions and also serves as a substrate for enzymes involved in cellular maintenance and signaling.
The confusing part is that a product labeled for “NAD+ support” may contain very different ingredients.
- NMN is nicotinamide mononucleotide, a direct precursor used in NAD+ biosynthesis.
- NR is nicotinamide riboside, another precursor that enters NAD+ biosynthesis.
- Direct NAD+ supplies the coenzyme itself through a particular oral formulation.
- Nicotinamide and niacin are vitamin B3 forms that can also feed NAD+ pathways.
- Blends combine one of these ingredients with other compounds.
If you want the underlying biology first, read What Is NAD+?. For shopping, the most useful distinction is simpler: NMN and NR have the deepest repeated oral human evidence for raising NAD+.[2]
CELLSHE EVIDENCE MAP
Which oral NAD+ options have the strongest human evidence?
| Form | Does it raise NAD+ in human studies? | What else has been seen? | Practical take |
|---|---|---|---|
| NMN | Yes, repeatedly. Randomized oral studies at 250 to 900 mg per day have increased blood or cellular NAD+ measures. | Positive signals include six-minute walking performance, muscle insulin sensitivity in a defined group of postmenopausal women, and some muscle-function measures in older men. | One of the two clearest evidence-based oral choices. |
| NR | Yes, repeatedly. Human trials have consistently shown NAD+ target engagement in blood and other measured compartments. | Some studies report vascular, inflammatory, or disease-specific signals. Results vary by population and endpoint. | Also one of the two clearest evidence-based oral choices. |
| Direct oral NAD+ | Promising, but early. A 2026 randomized trial showed a short-term rise in intracellular whole-blood NAD+ with one proprietary formulation. | That five-day study did not establish a broader clinical benefit. | Interesting emerging evidence, but not yet as established as NMN or NR. |
| Nicotinamide | It participates in NAD+ metabolism, but a 2026 head-to-head trial did not show the same sustained whole-blood NAD+ increase seen with NMN and NR. | It has its own vitamin and clinical uses outside the modern NAD+ precursor category. | Do not treat it as interchangeable with NMN or NR. |
CELLSHE interpretation: if your goal is an oral supplement with repeated human evidence for raising NAD+, the practical shortlist is NMN and NR. The direct-NAD category is worth watching, but it has not displaced the precursor evidence base.
Sources: Christen et al. 2026 [1]; Gallagher & Emmanuel 2026 [2]; Yi et al. 2023 [3]; Okabe et al. 2022 [4]; Igarashi et al. 2022 [5]; Yoshino et al. 2021 [6]; Martens et al. 2018 [7]; Kornilov et al. 2026 [9].
Why NMN is a serious evidence-based option
NMN is sometimes discussed as if the case for it were still mostly animal biology. That is no longer a fair summary.
Human trials now support a clear conclusion: oral NMN can raise NAD+ in people. The more interesting question is what else happens in different populations.
Healthy adults: blood NAD+ rises across several studied doses
In a randomized 60-day trial of 80 healthy middle-aged adults, daily NMN at 300, 600, or 900 mg increased blood NAD+ compared with placebo. All three NMN groups also improved six-minute walking distance more than placebo at the study visits, with the largest distances in the 600 and 900 mg groups.[3]
A separate randomized trial gave healthy adults 250 mg of NMN daily for 12 weeks. Whole-blood NAD+ increased significantly, and the supplement was well tolerated during the study.[4]
Older men: NAD+ rose, with muscle-function signals
In healthy older men, 250 mg of NMN daily for 6 or 12 weeks increased whole-blood NAD+ and related metabolites. The study also found nominal improvements in gait speed and left-hand grip performance, although those functional findings need confirmation in larger trials.[5]
Postmenopausal women: a positive metabolic trial
One of the most relevant NMN trials for women studied 25 postmenopausal women with prediabetes who were overweight or obese. After 10 weeks at 250 mg per day, NMN increased muscle insulin sensitivity and insulin signaling compared with placebo.[6]
This was a defined metabolic population, so it should be read for exactly what it measured. It is still important evidence because it shows that NMN research has moved beyond simply asking whether blood NAD+ changes.
The useful NMN conclusion: NMN has repeated randomized human evidence for raising NAD+, plus positive functional and metabolic findings in several studies. The health effects are not identical in every population, but NMN is clearly a human-studied NAD+ precursor, not merely a theoretical one.
NMN or NR: which one should you choose?
Both are legitimate choices if your primary goal is to use an oral NAD+ precursor with human evidence.
NR has a longer human clinical history. A well-known randomized crossover trial in healthy middle-aged and older adults showed that six weeks of NR effectively stimulated NAD+ metabolism and was well tolerated.[7]
NMN now has multiple randomized trials of its own, including healthy adults, older men, and postmenopausal women with prediabetes. The January 2026 head-to-head study adds an important piece: at 1,000 mg per day for 14 days, NMN and NR produced comparable increases in whole-blood NAD+.[1]
That makes the practical decision less dramatic than supplement marketing often suggests. You do not need to believe that one precursor has “won.” Choose a well-disclosed product, a dose with human context, reliable testing, and a format you can use consistently.
For a deeper molecule-by-molecule comparison, see NMN vs NR.
What does the human NMN dose range tell you?
Human NMN research has used a range of oral doses rather than one universal amount.
- 250 mg/day has been studied for 10 to 12 weeks in several human trials.[4][5][6]
- 300, 600, and 900 mg/day were studied side by side for 60 days in healthy middle-aged adults.[3]
- 500 mg has been administered as a single oral dose in an early human safety study, while higher daily intakes have also been studied in later trials.[12][8]
A 500 mg daily serving therefore sits inside the broader human NMN dosing landscape. That does not make 500 mg a universal optimum. It means it is a credible, research-contextualized amount rather than an arbitrary label number.
For a full dose-by-dose evidence map, use the dedicated NMN dosage guide.
CELLSHE TOOL
The NAD+ Supplement Memory Card
1. NAD+ is the target.
NMN and NR are precursors your body can use within NAD+ biosynthesis.
2. NMN and NR both work at raising NAD+.
Repeated human trials support both. A 2026 head-to-head study found comparable whole-blood NAD+ increases.
3. NMN has human outcome data too.
Trials have reported positive signals in walking performance, muscle insulin sensitivity, and some muscle-function measures.
4. Direct oral NAD+ is newer.
A 2026 randomized study is encouraging, but the evidence currently belongs to one tested formulation.
5. Product quality still decides what you are buying.
Check the active, daily amount, finished-product testing, current COA, and price per serving.
Your product check
Active:
Daily amount:
Current COA: ☐ Yes ☐ No
Finished-product potency: ☐ Yes ☐ No
CELLSHE synthesis from the human trials cited in this article.
What benefits can you reasonably expect from an NAD+ precursor?
The most dependable expectation is biochemical: NMN and NR can raise measured NAD+ or NAD-related metabolites in humans.[2]
Beyond that, the picture is more interesting than a simple yes or no.
NMN trials have produced positive findings in physical performance, muscle insulin sensitivity, and some muscle-function measures.[3][5][6] NR has also produced physiological and disease-specific signals in human work, while other trials have found little change in particular outcomes.
A 2026 systematic review of 33 human intervention studies summarized the field well: oral NMN and NR consistently showed biochemical target engagement and were generally well tolerated over weeks to months, while broader health outcomes varied by study and endpoint.[2]
For the detailed endpoint-by-endpoint science, see NAD+ Benefits: What the Science Says. This page stays focused on choosing the supplement category.
Do you need an NAD+ supplement just because you are over 40?
Age alone is not enough to tell you what your blood NAD+ level is.
A 2026 study across seven human cohorts found that whole-blood NAD+ remained fairly stable across age, even though it changed in response to precursor supplementation.[10]
This does not erase tissue-specific aging biology. It does make one common sales pitch much less useful: you should not assume a fixed percentage drop in blood NAD+ simply because you reached a certain birthday.
If you want the full age evidence, read NAD+ Levels by Age. If you are thinking about measuring your own level, use the NAD+ Blood Test guide.
How to choose a good NAD+ supplement
Once you have chosen the molecule, the rest of the decision is practical.
- Choose the exact active first. For the strongest repeated oral NAD+ evidence, start with NMN or NR.
- Check the daily amount. The active dose should be clearly stated, not hidden inside a proprietary blend.
- Look for finished-product testing. A useful Certificate of Analysis should correspond to the product or batch you may actually receive.
- Check potency as well as contaminants. Purity language is less useful if the finished product was never verified for how much active it contains.
- Compare price per disclosed daily serving. Do this after the product passes the evidence and quality checks.
FDA regulates dietary supplements, but it does not preapprove them for safety and effectiveness before they reach the market. That makes manufacturer quality controls, accurate labeling, and independent verification important parts of the buying decision.[11]
Why CELLSHE uses NMN: the evidence now supports NMN as one of the two established oral NAD+ precursor choices. CELLSHE NMN 500 provides 500 mg of beta-NMN as its single active ingredient. The amount is fully disclosed, and the product is third-party tested with a Certificate of Analysis available.
So, what is the best NAD+ supplement strategy?
For most people comparing oral NAD+ supplements, start with NMN or NR. They have the clearest repeated human evidence for raising NAD+.
NMN is a particularly strong option because it now combines repeated NAD+ target-engagement data with positive functional and metabolic findings in several randomized human trials. NR is also well supported and remains a valid precursor choice.
Direct oral NAD+ has become scientifically more interesting in 2026, but its human evidence is still much narrower. It belongs in the emerging category, not at the center of the buying decision.
The simple rule to remember is this: choose the molecule first, verify the product second, and treat the health outcomes as a growing human evidence base rather than a marketing promise.
References
- Christen S, Redeuil K, Goulet L, et al. (2026). The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. PMID: 41540253. DOI: 10.1038/s42255-025-01421-8. PubMed.
- Gallagher C, Emmanuel OO. (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. PMID: 41655607. DOI: 10.1016/j.arr.2026.103057. PubMed.
- Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of beta-nicotinamide mononucleotide supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, dose-dependent clinical trial. GeroScience. PMID: 36482258. DOI: 10.1007/s11357-022-00705-1. PubMed.
- Okabe K, Yaku K, Uchida Y, et al. (2022). Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Frontiers in Nutrition. PMID: 35479740. PubMed.
- Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. PMID: 35927255. DOI: 10.1038/s41514-022-00084-z. PubMed.
- Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. PMID: 33888596. DOI: 10.1126/science.abe9985. PubMed.
- Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. PMID: 29599478. DOI: 10.1038/s41467-018-03421-7. PubMed.
- Pencina KM, et al. (2023). Nicotinamide adenine dinucleotide augmentation in overweight or obese middle-aged and older adults: a physiologic study. Journal of Clinical Endocrinology & Metabolism. PMID: 36740954. PubMed.
- Kornilov SA, Hastings WJ, McGrath LF, et al. (2026). Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial. GeroScience. PMID: 42530810. DOI: 10.1007/s11357-026-02399-1. PubMed.
- Trętowicz MM, Scantlebery AML, Schomakers BV, et al. (2026). Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nature Metabolism. PMID: 42135539. PubMed.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. FDA.
- Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. PMID: 31685720. DOI: 10.1507/endocrj.EJ19-0313. PubMed.
